This area of our site caters to GPs, sleep therapists and sleep lab nurses.
If you are a patient, commercial partner or hospital specialist, visit our homepage for more options.
With ResMed, your patients won’t need to walk the therapy journey alone. We’re here to offer help and support along the way, so they can get the most out of their therapy.
Direct your patients to these pages for help with their ResMed product.
ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnoea.